Cranial Nerve Stimulation: Old and New Neuromodulation Therapies for CNS Disorders​

 

You’re invited to join the Clinical TMS Society for the next installment of our Grand Rounds Webinar Series: Cranial Nerve Stimulation: Old and New Neuromodulation Therapies for CNS Disorders. Speaker Dr. Ian A. Cook will be discussing the neurobiological basis for cranial nerve therapies such as trigeminal nerve stimulation and the clinical research to match patient to treatment more effectively.

Attendees will be able to:

  • To describe the relationship between cranial nerve circuitry and higher cortical and subcortical structures involved in neuropsychiatric disorders
  • To evaluate the preclinical, translational, and clinical trials data on new cranial nerve stimulation modalities such as trigeminal nerve stimulation (TNS)
  • To consider the evidence base of TNS in epilepsy,depression, PTSD, ADHD, and migraine, and regulatory approvals in the EU, Canada, Australia, and the U.S. 

Date: Tuesday, June 6 2017

Time: 8:00pm (EST) / 5:00pm (PST) 

Format: Webinar using Zoom Video Communications

Cost: Members: $25 | Non-members: $50


Speaker: Ian A. Cook, MD

Ian A. Cook, MD, is a Professor of Psychiatry and Biobehavioral Sciences and of Bioengineering at UCLA, where he founded the TMS program in 2009. He is the Director of the UCLA Depression Research & Clinic program and was the first to hold the Miller Family Endowed Chair in Depression Research.  He has lead translational research projects for over 20 years at UCLA, initially focusing on neurophysiological and neuroimaging biomarkers related to treatment for depression and dementia, and more recently on treatment development using neuromodulation approaches. He has been PI on research grants examining vagus nerve stimulation, transcranial magnetic stimulation, and trigeminal nerve stimulation.  He was the first physician to use trigeminal nerve stimulation as a psychiatric treatment, initially in major  depression and then in PTSD, and is an inventor on over 25 issued and provisional U.S. patents for neuromodulation devices and methods. He has published over 120 original research reports, along with dozens of review articles, book chapters, and invited editorial sand commentaries.

Dr. Cook graduated from Princeton University with a B.S.E. in Electrical Engineering and Computer Science and Bioengineering, where his thesis examined the effects of electromagnetic fields on biological tissues. He graduated from the Yale School of Medicine before coming to UCLA for his psychiatry residency and NIMH research fellowship.  He was elected Chair of the Faculty of the UCLA School of Medicine and simultaneously served as Chief of Staff of the Resnick Neuropsychiatric Hospital at UCLA.  A Distinguished Fellow of the APA, he served on its Steering Committee on Practice Guidelines for 14 years, and led its electronic dissemination of evidence-based guidelines while serving on its Executive Committee.  In 2011, he was tapped by Thomas Insel MD, then Director of the NIMH, to serve as a standing member of the Interventions Committee for Adult Disorders (ITVA) review group. Dr. Cook was elected to the Board of Directors of the Clinical TMS Society in 2013, the year it was founded.